Prospective associations of dietary carbohydrate, fat, and protein intake with β-cell function in the CODAM study.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 20 07 2017
accepted: 19 02 2018
pubmed: 12 3 2018
medline: 4 9 2019
entrez: 12 3 2018
Statut: ppublish

Résumé

Type 2 diabetes mellitus (T2DM) is characterized by both impaired pancreatic β-cell function (BCF) and insulin resistance. In the etiology of T2DM, BCF basically determines whether a person with a certain degree of insulin resistance develops T2DM, as β-cells are able to compensatorily increase insulin secretion. The effects of dietary intake on BCF are largely unknown. Our study aim was to investigate whether dietary macronutrient intake predicts BCF. Prospective data (median follow-up 7 years) of 303 individuals recruited from the CODAM study population (aged 40-70 years, 39% women) were analyzed. BCF was measured by C-peptide deconvolution and physiological modeling of data from a 5-point, 75-g, 2-h oral glucose tolerance test. Macronutrient intake was estimated by a 178-item Food Frequency Questionnaire. Associations adjusted for relevant covariates of baseline macronutrient intake with model-derived parameters describing BCF (glucose sensitivity, rate sensitivity or potentiation) or C-peptidogenic index were detected for trans fat [standardized regression coefficient (95%-CI) glucose sensitivity - 0.14 (- 0.26, - 0.01)] per g, cholesterol [potentiation 0.20 (0.02, 0.37)] per 100 mg, dietary fiber [glucose sensitivity 0.21 (0.08, 0.33)] per 10 g, MUFA glucose sensitivity 0.16 (0.02, 0.31) per 10 g, and polysaccharide [potentiation - 0.24 (- 0.43, - 0.05), C-peptidogenic index - 0.16 (- 0.29 - 0.03); odds ratio lowest versus highest tertile (95%-CI) rate sensitivity 1.51 (1.06, 2.15)) per 50 g. In this population at high risk for developing T2DM, polysaccharide and trans fat intake were associated with worse BCF, whereas increased intake of MUFA, dietary cholesterol, and fiber were associated with better BCF.

Identifiants

pubmed: 29525890
doi: 10.1007/s00394-018-1644-y
pii: 10.1007/s00394-018-1644-y
pmc: PMC6437317
doi:

Substances chimiques

Dietary Carbohydrates 0
Dietary Fats 0
Dietary Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

597-608

Références

Obesity (Silver Spring). 2008 Aug;16(8):1901-7
pubmed: 18551118
Diabetologia. 2001 Mar;44(3):312-9
pubmed: 11317662
Am J Clin Nutr. 2001 Jun;73(6):1019-26
pubmed: 11382654
Diabetes Metab Res Rev. 2001 Mar-Apr;17(2):137-45
pubmed: 11307179
Am J Clin Nutr. 2014 Jul;100(1):218-32
pubmed: 24787496
Am J Clin Nutr. 2015 Dec;102(6):1543-53
pubmed: 26537938
J Am Coll Nutr. 2012 Aug;31(4):243-58
pubmed: 23378452
Am J Epidemiol. 2004 Sep 1;160(5):436-44
pubmed: 15321840
BMJ. 2006 May 6;332(7549):1080
pubmed: 16675816
Diabetologia. 2003 Sep;46(9):1211-9
pubmed: 12879253
Clin Chim Acta. 2004 Mar;341(1-2):33-40
pubmed: 14967156
Nutr Metab Cardiovasc Dis. 2004 Dec;14(6):373-94
pubmed: 15853122
Mol Nutr Food Res. 2015 Sep;59(9):1791-802
pubmed: 26080997
Diabetes Care. 2005 Dec;28(12):2832-8
pubmed: 16306541
Diabetes Care. 1997 Apr;20(4):545-50
pubmed: 9096978
Can J Diabetes. 2013 Apr;37 Suppl 1:S45-55
pubmed: 24070963
Curr Diabetes Rev. 2014 Jan;10(1):2-42
pubmed: 24524730
Diabetes Care. 2007 Nov;30(11):2811-3
pubmed: 17712022
Diabetes Care. 2008 Dec;31(12):2281-3
pubmed: 18835944
Diabetologia. 2004 May;47(5):943-56
pubmed: 15105990
Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E1-E15
pubmed: 17341552
Clin Sci (Lond). 2004 Feb;106(2):191-9
pubmed: 14561212
Am J Physiol Endocrinol Metab. 2014 Nov 1;307(9):E822-9
pubmed: 25184989
Int J Epidemiol. 1997;26 Suppl 1:S37-48
pubmed: 9126532
Am J Clin Nutr. 2003 Feb;77(2):385-91
pubmed: 12540398
Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1159-66
pubmed: 12388151
J Lipid Res. 2006 Dec;47(12):2799-807
pubmed: 16971732
Metabolism. 2014 Oct;63(10):1217-27
pubmed: 25070616
Lancet Diabetes Endocrinol. 2017 Dec;5(12):965-974
pubmed: 29032079
Am J Public Health. 2000 Sep;90(9):1409-15
pubmed: 10983198
Diabetes Res Clin Pract. 2011 Dec;94(3):311-21
pubmed: 22079683
Eur J Clin Invest. 2011 Apr;41(4):372-9
pubmed: 21114489
Br J Nutr. 2014 Nov 14;112(9):1530-41
pubmed: 25230681
Int J Epidemiol. 1997;26 Suppl 1:S49-58
pubmed: 9126533
Diabetologia. 2017 Mar;60(3):432-441
pubmed: 27933333
J Clin Endocrinol Metab. 2005 Jan;90(1):493-500
pubmed: 15483086
Br J Nutr. 2008 May;99(5):1107-16
pubmed: 17988431
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Lancet. 2011 Jul 9;378(9786):169-81
pubmed: 21705072
J Clin Epidemiol. 2003 Dec;56(12):1163-9
pubmed: 14680666
Biochem Soc Trans. 2008 Oct;36(Pt 5):905-8
pubmed: 18793159
Lancet Diabetes Endocrinol. 2014 Oct;2(10):810-8
pubmed: 25107467
Diabetes Care. 2014 Jan;37 Suppl 1:S120-43
pubmed: 24357208
Diabetes Care. 2003 Jul;26(7):1979-85
pubmed: 12832299
J Nutr Biochem. 2015 Jun;26(6):571-84
pubmed: 25841249
Eur J Clin Nutr. 2006 Oct;60(10):1195-200
pubmed: 16639414
Diabetes Care. 1992 Jul;15(7):815-9
pubmed: 1516497
Diabetes Care. 2004 Nov;27(11):2701-6
pubmed: 15505008
Am J Clin Nutr. 2010 Oct;92(4):905-11
pubmed: 20685945
Diabetes Metab Res Rev. 2012 Jan;28(1):25-49
pubmed: 21695766
Lancet. 2012 Jun 16;379(9833):2279-90
pubmed: 22683128
Diabetes. 2002 Feb;51 Suppl 1:S212-20
pubmed: 11815482
Arch Intern Med. 2007 May 14;167(9):956-65
pubmed: 17502538
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
Nutr Metab Cardiovasc Dis. 2007 Oct;17(8):572-80
pubmed: 17127043
Diabetes Care. 2001 Sep;24(9):1528-35
pubmed: 11522694
Eur J Clin Invest. 2009 Jun;39(6):437-44
pubmed: 19397692
Am J Clin Nutr. 2000 Apr;71(4):921-30
pubmed: 10731498

Auteurs

Louise J C J den Biggelaar (LJCJ)

Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Simone J P M Eussen (SJPM)

Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. simone.eussen@maastrichtuniversity.nl.
School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands. simone.eussen@maastrichtuniversity.nl.
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands. simone.eussen@maastrichtuniversity.nl.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands. simone.eussen@maastrichtuniversity.nl.

Simone J S Sep (SJS)

Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Centre of Expertise in Rehabilitation and Audiology, Adelante, Hoensbroek, The Netherlands.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Andrea Mari (A)

CNR Institute of Clinical Physiology, Pisa, Italy.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Ele Ferrannini (E)

CNR Institute of Neuroscience, Padova, Italy.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Marleen M van Greevenbroek (MM)

School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Carla J van der Kallen (CJ)

School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Casper G Schalkwijk (CG)

School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Ilja C W Arts (ICW)

School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands.
Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, The Netherlands.

Coen D A Stehouwer (CDA)

School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Pieter C Dagnelie (PC)

Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, The Netherlands.
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH